PD-L1 and PD-L2 differ in expression patterns but have the same effect, and binding of PD-1 to either ligand leads to T-cell dysfunction or exhaustion, resulting in diminished intensity of antigen-specific T-cell response in tumor tissues (18–21). Here, PDCD1 is linked to neoplasm.